Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.

OBJECTIVE To study the phenotypic characteristics of patients with a novel p.E292K mutation in BEST1. METHODS Affected individuals underwent ophthalmic examination and testing that included photography, autofluorescence, optical coherence tomography, and electrophysiological testing. Their DNA was analyzed for BEST1 mutations. RESULTS Five patients aged 5 to 59 years who expressed the p.E292K mutation in BEST1 were identified in 3 families. Electro-oculographic light-rise was subnormal in all probands and carriers. Carriers had normal findings from fundus examination, multifocal electroretinography, and visual acuity, and were emmetropic or myopic. Only probands had hyperopia and fundus findings typical of Best macular dystrophy. Optical coherence tomography of vitelliform lesions demonstrated retinal pigment epithelium elevation without subretinal fluid; atrophic lesions exhibited disruption of the hyperreflective outer retina-retinal pigment epithelium complex. Intense hyperautofluorescence correlated with the vitelliform lesion. CONCLUSIONS Patients with the Glu292Lys variation in BEST1 exhibit intrafamilial and interfamilial phenotypic variability. A disproportionate fraction (26%) of Best disease-causing mutations occurs in exon 8, suggesting that the portion of protein encoded by this exon (amino acids 290-316) may be especially important to bestrophin's function. Relatively good visual acuity with vitelliform lesions can be explained by preservation of the outer retina, demonstrated by optical coherence tomography. Clinical Relevance A novel mutation in this region of BEST1 carries implications for disease pathogenesis.

[1]  E. Souied,et al.  High-definition optical coherence tomography features in vitelliform macular dystrophy. , 2008, American journal of ophthalmology.

[2]  H. C. Hartzell,et al.  The Best Disease-Linked Cl− Channel hBest1 Regulates CaV1 (L-type) Ca2+ Channels via src-Homology-Binding Domains , 2008, The Journal of Neuroscience.

[3]  G. Holder,et al.  Biallelic mutation of BEST1 causes a distinct retinopathy in humans. , 2008, American journal of human genetics.

[4]  E. Stone,et al.  Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. , 2007, Investigative ophthalmology & visual science.

[5]  A. Swaroop,et al.  High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. , 2007, Investigative ophthalmology & visual science.

[6]  C. Wadelius,et al.  Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). , 2007, Experimental eye research.

[7]  F. Torricelli,et al.  A novel mutation in the VMD2 gene in an Italian family with Best maculopathy. , 2007, Journal francais d'ophtalmologie.

[8]  G. Acland,et al.  Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. , 2007, Investigative ophthalmology & visual science.

[9]  P. Campochiaro,et al.  VMD2 Promoter Requires Two Proximal E-box Sites for Its Activity in Vivo and Is Regulated by the MITF-TFE Family* , 2007, Journal of Biological Chemistry.

[10]  V. Drouin‐Garraud,et al.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy , 2006, Journal of Medical Genetics.

[11]  K. Freund,et al.  Vitelliform macular dystrophy. , 2014, JAMA ophthalmology.

[12]  G. Fishman,et al.  Novel de novo mutation in a patient with Best macular dystrophy. , 2006, Archives of ophthalmology.

[13]  Kang Zhang,et al.  A novel mutation of the VMD2 gene in a Chinese family with best vitelliform macular dystrophy. , 2006, Annals of the Academy of Medicine, Singapore.

[14]  N. Peachey,et al.  The Light Peak of the Electroretinogram Is Dependent on Voltage-gated Calcium Channels and Antagonized by Bestrophin (Best-1) , 2006, The Journal of general physiology.

[15]  B. Lorenz,et al.  Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  N. Dahl,et al.  Variant Phenotype of Best Vitelliform Macular Dystrophy Associated with Compound Heterozygous Mutations in VMD2 , 2006, Ophthalmic genetics.

[17]  C. Wadelius,et al.  Expression of bestrophin‐1, the product of the VMD2 gene, modulates voltage‐dependent Ca2+ channels in retinal pigment epithelial cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  E. Stone,et al.  Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. , 2005, Archives of ophthalmology.

[19]  U. Kellner,et al.  Late onset is common in best macular dystrophy associated with VMD2 gene mutations. , 2005, Ophthalmology.

[20]  C. Wadelius,et al.  A model of best vitelliform macular dystrophy in rats. , 2004, Investigative ophthalmology & visual science.

[21]  D. Baralle,et al.  Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). , 2004, Investigative ophthalmology & visual science.

[22]  P. Campochiaro,et al.  Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its Regulation* , 2004, Journal of Biological Chemistry.

[23]  U. Kellner,et al.  Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD) , 2003, Human mutation.

[24]  J. Nathans,et al.  Structure-Function Analysis of the Bestrophin Family of Anion Channels* , 2003, Journal of Biological Chemistry.

[25]  A. Hutchinson,et al.  Phenotype and genotype correlations in two best families. , 2003, Ophthalmology.

[26]  Donald C. Hood,et al.  Guidelines for basic multifocal electroretinography (mfERG) , 2003, Documenta Ophthalmologica.

[27]  Edwin M Stone,et al.  In vivo micropathology of Best macular dystrophy with optical coherence tomography. , 2003, Experimental eye research.

[28]  Richard F Spaide,et al.  Fundus autofluorescence and age-related macular degeneration. , 2003, Ophthalmology.

[29]  M. Schmid,et al.  Three novel human VMD2-like genes are members of the evolutionary highly conserved RFP-TM family , 2002, European Journal of Human Genetics.

[30]  J. Nathans,et al.  The vitelliform macular dystrophy protein defines a new family of chloride channels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Dollfus,et al.  Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy , 2002, Ophthalmic genetics.

[32]  E. Stone,et al.  VISUAL OUTCOME FOLLOWING SUBRETINAL HEMORRHAGE IN BEST DISEASE , 2001, Retina.

[33]  D. Schorderet,et al.  Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy , 2001, Human mutation.

[34]  C. Wadelius,et al.  Best’s vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene , 2001, Ophthalmic genetics.

[35]  J. Hollyfield,et al.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Sheffield,et al.  Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[37]  A. Marquardt,et al.  VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies , 2000, Human mutation.

[38]  B. Lorenz,et al.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration , 2000, European Journal of Human Genetics.

[39]  N. Orzalesi,et al.  A novel spontaneous missense mutation in VMD2 gene is a cause of a best macular dystrophy sporadic case. , 2000, American journal of ophthalmology.

[40]  P. Sieving,et al.  Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. , 1999, Genomics.

[41]  C. Wadelius,et al.  The mutation spectrum of the bestrophin protein – functional implications , 1999, Human Genetics.

[42]  M. Marmor,et al.  Standard for clinical electroretinography (1999 update) , 1998, Documenta Ophthalmologica.

[43]  H. Stöhr,et al.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). , 1998, Human molecular genetics.

[44]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.

[45]  F W Fitzke,et al.  In vivo fundus autofluorescence in macular dystrophies. , 1997, Archives of ophthalmology.

[46]  G. Fishman,et al.  Visual acuity in patients with best vitelliform macular dystrophy. , 1993, Ophthalmology.

[47]  M. Marmor,et al.  Standard for clinical electro-oculography , 1993, Documenta Ophthalmologica.

[48]  R. Weleber Fast and slow oscillations of the electro-oculogram in Best's macular dystrophy and retinitis pigmentosa. , 1989, Archives of ophthalmology.

[49]  G. Fishman,et al.  Histopathologic findings in Best's vitelliform macular dystrophy. , 1988, Archives of ophthalmology.

[50]  S. Fine,et al.  A histopathologic study of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[51]  J. Kobrin,et al.  Histopathology of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[52]  C. W. Mohler,et al.  Long-term evaluation of patients with Best's vitelliform dystrophy. , 1981, Ophthalmology.

[53]  G. Bresnick,et al.  Choroidal neovascular membrane in Best's vitelliform macular dystrophy. , 1976, American journal of ophthalmology.

[54]  H. Cross,et al.  Genetic counseling of families with Best macular dystrophy. , 1975, Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology.

[55]  A. Deutman Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. , 1969, Archives of ophthalmology.

[56]  A. M. Potts,et al.  Hereditary vitelliruptive macular degeneration. , 1966, American journal of ophthalmology.